1. Taiwan, Province of China Stocks

  2. •

    Industrials

  3. •

    Medical - Distribution
Carilex

Carilex

7726.TWO
CarilexTW flagTaipei Exchange
33.85
TWD
- -
- -
687.29MMarket Cap
Carilex
7726.TWO
(Taipei Exchange)

Recent

price

33.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
FRC
25.58
28.41
20.13
26.15
17.32
- -
Revenue per Share
3.91
2.37
1.73
2.49
0.66
- -
Basic EPS, GAAP
3.26
5.66
0.29
-0.26
1.09
- -
Free Cash Flow per Basic Share
- -
3.55
- -
- -
1.77
- -
Dividend per Share
13.97
12.54
12
15.46
12.26
- -
Book Value per Share
15.85
14.88
13.14
18.59
15.4
- -
Tangible Book Value per Share
14
14
17
18
20
- -
Basic Weighted Avg Shares
347
388
335
466
352
339
Sales/Revenue/Turnover
21
13.47
5.24
11.88
0.86
-12.63
Operating Margin (%)
17
17
19
21
25
31
Depreciation Expense
53
32
29
44
13
-29
Net Income, GAAP
20.03
22.63
19.93
21.25
19.38
- -
Effective Tax Rate (%)
15.29
8.34
8.61
9.53
3.83
-8.56
Profit Margin (%)
183
177
187
296
277
210
Working Capital
28
35
22
7
8
15
LT Debt
216
204
237
351
330
291
Total Equity
- -
13.05
4.3
11.12
0.57
- -
Return on Invested Capital (%)
- -
12.48
10.75
14.41
4.39
- -
Return on Capital (%)
- -
17.93
15.56
18.69
5.14
-12.71
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
8.21%
-11.85%
Free Cash Flow
- -
-144.26%
63.49%
Net Income, GAAP
- -
-76.12%
-315.05%
Sales/Revenue/Turnover
- -
1.77%
-3.72%
Total Cash Common Dividend
- -
- -
-67.8%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
466
2024
- -
- -
- -
- -
352
2025
- -
- -
- -
- -
339

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.49
2024
- -
- -
- -
- -
0.66
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
1.77
2025
- -
- -
- -
- -
- -
Similar Companies
Nexus Surgical & Medicare Ltd. (NEXUSSURGL.BO)
Suzuken Co., Ltd. (SZUKF)
Apex Healthcare Berhad (7090.KL)
Medios AG (MEDOF)
McKesson Corporation (0JZU.L)
Saintmed Public Company Limited (SMD.BK)
Business
Carilex Medical Inc (7726.TWO) manufactures and sells medical devices focused on pressure ulcer prevention and wound care management worldwide. The company offers therapeutic support surfaces including alternating pressure air mattresses such as TheraFlo AP 7&9, DualGT, DualPlus, CozinyPlus, Entrix NX, DualFlex, TheraFlo, AVA LAL, and Envelop; chair cushions like CariChair; and negative pressure wound therapy (NPWT) systems comprising suction pumps such as VT- 100, VT- ONE, and VT- 200, along with NPWT dressing kits and canisters. Founded in 1985 and headquartered in Taoyuan City, Taiwan, Carilex operates globally with subsidiaries and presence in Europe, the United States, Australia, and the Middle East, serving medical wards, acute care units, nursing institutions, and home care settings. In recent developments, the company obtained class IIa CE Mark certification under the EU Medical Device Regulation (MDR) for its alternating pressure air mattresses in 2023; launched innovative NPWT solutions and portable products like VT- ONE for small wound management; expanded market presence through participation in major trade shows including Arab Health 2024, EWMA conferences, Medica 2024, and Taiwan Healthcare Expo; and strengthened its European operations via a UK subsidiary to enhance localized services and NPWT device adoption.